{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:13:40Z","timestamp":1794618820326,"version":"4.9.1"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Despite the increasing use of coronary computed tomographic angiography (CCTA) in patients with known or suspected coronary artery disease (CAD), comparatively little is known about its predictive value for adverse events or clinical applicability of volumetric plaque analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the incremental prognostic value of quantitative CAD measures in symptomatic outpatients without known CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This post hoc analysis involved a prospective randomized clinical trial conducted across 193 clinical sites in North America. Participants were symptomatic outpatients without known CAD who were randomized to receive CCTA. The trial was conducted from July 27, 2010, to October 31, 2014, and the data analyzed for this report from January 2021 to July 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Core laboratory-based quantitative plaque measures, including total plaque volume (TPV), calcified (CPV) and noncalcified (NCPV) plaque volume, low-attenuation plaque volume (LAPV), total plaque burden (TPB), and noncalcified plaque burden (NCPB), normalized with vessel volume.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was major adverse cardiovascular events MACE (composite of death, nonfatal myocardial infarction, or hospitalization for unstable angina). Optimal predictive cut points for plaque measures were identified using Euclidean distance methods and tested in multivariable Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 4267 patients, the mean (SD) age was 60.4 (8.2) years; 2199 patients (51.5%) were female and 2068 (48.5%) were male. The median (IQR) TPV was 39.8 mm\n                      <jats:sup>3<\/jats:sup>\n                      (0-167) mm\n                      <jats:sup>3<\/jats:sup>\n                      . Patients with TPV at the median or higher were older (mean [SD] age, 62.1 [8.4] vs 58.7 [7.5] years for those with lower than median TPV), more likely to be male (1286\/2133 [60.3%] vs 782\/2134 [36.6%], respectively), and had higher median (IQR) atherosclerotic cardiovascular disease risk scores (14.4 [8.8-24.0] vs 7.9 [4.5-13.4], respectively). TPB showed similar demographic associations. Both TPB and NCPB independently predicted MACE after adjusting for clinical risk factors, statin use, and qualitative CCTA findings (TPB: adjusted HR [aHR], 1.18; 95% CI, 1.05-1.34;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.006; NCPB: aHR, 1.20; 95% CI, 1.05-1.37;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.007). Optimal cutoffs of TPV 87 mm\n                      <jats:sup>3<\/jats:sup>\n                      or greater, TPB 35% or greater, and NCPB 20% or greater were each associated with nearly a 2-fold increase in MACE risk (TPV: aHR, 2.07; 95% CI, 1.24-3.49; TPB: aHR, 1.96; 95% CI, 1.21-3.17; and NCPB: aHR, 1.77; 95% CI, 1.12-2.82).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In symptomatic patients without known CAD, coronary plaque volumes and burdens are low but are related to CAD risk factors and independently predictive of MACE. The clinical utility of quantitative CCTA-based cardiovascular risk estimation in early CAD requires prospective evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01174550\">NCT01174550<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.5520","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:30:36Z","timestamp":1770827436000},"page":"259","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease"],"prefix":"10.1001","volume":"11","author":[{"given":"J\u00falia","family":"Kar\u00e1dy","sequence":"first","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"},{"name":"Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Heart and Vascular Center, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mayrhofer","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"},{"name":"Center for Preventive Medicine and Digital Health, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Brendel","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rton","family":"Kolossv\u00e1ry","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"},{"name":"Gottsegen National Cardiovascular Center, Budapest, Hungary"},{"name":"Physiological Controls Research Center, University Research and Innovation Center, \u00d3buda University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Langenbach","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Langenbach","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit","family":"Baliyan","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra K.","family":"Sturniolo","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pagidipati","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maros","family":"Ferencik","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"},{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svati","family":"Shah","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borek","family":"Foldyna","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Radiology Department, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"hoi250081r1","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1161\/CIR.0000000000001029","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"issue":"36","key":"hoi250081r2","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes.","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"11","key":"hoi250081r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2024.102230","article-title":"The role of cardiac computed tomography angiography in risk stratification for coronary artery disease.","volume":"3","author":"van Rosendael","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"24","key":"hoi250081r4","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"hoi250081r5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial.","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"7","key":"hoi250081r6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10554-013-0232-8","article-title":"Coronary computed tomography angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden.","volume":"29","author":"de Ara\u00fajo Gon\u00e7alves","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"issue":"18","key":"hoi250081r7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"hoi250081r8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial.","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"5","key":"hoi250081r9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcct.2024.05.232","article-title":"Standards for quantitative assessments by coronary computed tomography angiography (CCTA): an expert consensus document of the society of cardiovascular computed tomography (SCCT).","volume":"18","author":"Nieman","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"4","key":"hoi250081r10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jcct.2025.05.003","article-title":"Plaque quantification from coronary computed tomography angiography in predicting cardiovascular events: A systematic review and meta-analysis.","volume":"19","author":"Bell","year":"2025","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"22","key":"hoi250081r12","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","article-title":"Coronary atherosclerotic precursors of acute coronary syndromes.","volume":"71","author":"Chang","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10486","key":"hoi250081r13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"hoi250081r14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ahj.2014.03.003","article-title":"Prospective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial.","volume":"167","author":"Douglas","year":"2014","journal-title":"Am Heart J"},{"issue":"14","key":"hoi250081r15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease.","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"hoi250081r16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: endorsed by the North American Society for Cardiovascular Imaging (NASCI).","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"hoi250081r17","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00330-015-3698-z","article-title":"Clinical feasibility of 3D automated coronary atherosclerotic plaque quantification algorithm on coronary computed tomography angiography: comparison with intravascular ultrasound.","volume":"25","author":"Park","year":"2015","journal-title":"Eur Radiol"},{"issue":"5","key":"hoi250081r18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10554-013-0194-x","article-title":"Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology.","volume":"29","author":"de Graaf","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"hoi250081r19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography.","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi250081r20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcct.2022.09.003","article-title":"2022 use of coronary computed tomographic angiography for patients presenting with acute chest pain to the emergency department: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT): endorsed by the American College of Radiology (ACR) and North American Society for cardiovascular Imaging (NASCI).","volume":"17","author":"Maroules","year":"2023","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"hoi250081r21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study.","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"hoi250081r22","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1161\/CIRCULATIONAHA.120.049840","article-title":"Response by Williams et al to letter regarding article, \u201cLow-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)\u201d.","volume":"142","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"hoi250081r23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcct.2020.01.012","article-title":"Percent atheroma volume: optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study.","volume":"14","author":"van Rosendael","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"hoi250081r24","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi250081r25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/ehjci\/jeaa228","article-title":"Quantified coronary total plaque volume from computed tomography angiography provides superior 10-year risk stratification.","volume":"22","author":"Deseive","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"hoi250081r26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jcmg.2021.02.026","article-title":"Prognostic value of RCA pericoronary adipose tissue CT-attenuation beyond high-risk plaques, plaque volume, and ischemia.","volume":"14","author":"van Diemen","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"hoi250081r27","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jcmg.2024.06.015","article-title":"Polygenic risk is associated with long-term coronary plaque progression and high-risk plaque.","volume":"17","author":"Nurmohamed","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"hoi250081r28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.123.016143","article-title":"Interaction of AI-enabled quantitative coronary plaque volumes on coronary CT angiography, FFRCT, and clinical outcomes: a retrospective analysis of the ADVANCE registry.","volume":"17","author":"Dundas","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"hoi250081r29","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1016\/S2589-7500(22)00022-X","article-title":"Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study.","volume":"4","author":"Lin","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"5","key":"hoi250081r30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ehjci\/jey182","article-title":"Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial.","volume":"20","author":"Foldyna","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"hoi250081r31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jcmg.2012.03.019","article-title":"The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography.","volume":"5","author":"Maurovich-Horvat","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"hoi250081r32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jcmg.2010.02.003","article-title":"The napkin-ring sign: CT signature of high-risk coronary plaques?","volume":"3","author":"Maurovich-Horvat","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"hoi250081r11","unstructured":"US Food and Drug Administration. DDT-BMQ-000161, Coronary artery non-calcified plaque volume (NCPV) for detection and quantification of atherosclerotic CAD. Accessed May 1, 2025. https:\/\/force-dsc.my.site.com\/ddt\/s\/ddt-project?ddtprojectid=204"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2844868\/jamacardiology_kardy_2026_oi_250081_1773061323.12447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:00:51Z","timestamp":1773241251000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2844868"}},"subtitle":["A Substudy of the PROMISE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.5520","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}